Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
about
Response to and toxicity of gemcitabine for recurrent ovarian cancer according to number of previous chemotherapy regimens.Efficacy of capecitabine-based combination therapy and single-agent capecitabine maintenance therapy in patients with metastatic breast cancerMetastatic and triple-negative breast cancer: challenges and treatment options
P2860
Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
description
im Oktober 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 09 August 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2014
@uk
name
Phase II gemcitabine and capec ...... with anthracycline and taxane
@en
Phase II gemcitabine and capec ...... with anthracycline and taxane
@nl
type
label
Phase II gemcitabine and capec ...... with anthracycline and taxane
@en
Phase II gemcitabine and capec ...... with anthracycline and taxane
@nl
prefLabel
Phase II gemcitabine and capec ...... with anthracycline and taxane
@en
Phase II gemcitabine and capec ...... with anthracycline and taxane
@nl
P2093
P2860
P50
P1476
Phase II gemcitabine and capec ...... with anthracycline and taxane
@en
P2093
Hei-Cheul Jeung
Seungtaek Lim
Woo Ick Yang
P2860
P2888
P304
P356
10.1007/S00280-014-2551-4
P407
P50
P577
2014-08-09T00:00:00Z